论药物评价与医务人员的崇高职责
Drug evaluation and supreme responsibility of medical practitioners
出处
《中华内科杂志》
CAS
CSCD
北大核心
2005年第8期564-565,共2页
Chinese Journal of Internal Medicine
二级参考文献6
-
1Collins R,Peto R,MacMahon S,et al.Blood pressure, stroke, and coronary heart disease.Part 2, Short-term reductions in blood pressure:overview of randomised drug trials in their epidemiological context[].The Lancet.1990
-
2Silverstein FE,Faich G,Goldstein JL,et al.Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-infla mmatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial.Celecoxib Long-term Arthritis Safety Study[].The Journal of The American Medical Association.2000
-
3Sanmuganathan PS,Ghahramani P,Jackson PR,et al.Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials[].Heart.2001
-
4Bombardier C,Laine L,Reicin A,et al.Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.VIGOR Study Group[].The New England Journal of Medicine.2000
-
5McAdam BF,Catella-Lawson F,Mardini IA,et al.Systemic biosynthesis of prostacyclin by cyclooxygenase ( COX)-2: the human pharmacology of a selective inhibitor of COX-2[].Proceedings of the National Academy of Sciences of the United States of America.1999
-
6Yusuf S,Sleight P,Pogue J,et al.Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.The Heart Outcomes Prevention Evaluation Study Investigators[].The New England Journal of Medicine.2000
共引文献11
-
1陶元锦.非甾体类抗炎药物治疗类风湿关节炎近况[J].浙江中西医结合杂志,1997,7(4):217-218. 被引量：1
-
2卢思俭.类风湿性关节炎活动期中医药治疗近况[J].浙江中医杂志,1997,32(6):281-282. 被引量：2
-
3郭凤莲,韩超,刘清平,刘丽娟.通痹合剂结合中医辨证治疗类风湿关节炎90例临床观察[J].中医杂志,2008,49(10):897-900. 被引量：2
-
4戴冽,汤美安.类风湿关节炎的诊断与治疗体会[J].新医学,1998,29(2):61-63. 被引量：13
-
5陈鹏.中西医“同病异治、异病同治”比较的启示[J].中国中医药现代远程教育,2010,8(24):45-46. 被引量：2
-
6周林.慢作用抗风湿药在类风湿性关节炎中的应用[J].临床荟萃,2001,16(5):238-239. 被引量：1
-
7刘继华,刘秋莹.类风湿性关节炎的药物治疗现状[J].临床医学,2001,21(4):39-41. 被引量：1
-
8陈琳洁,刘超,李志军.老年人类风湿关节炎57例分析[J].蚌埠医学院学报,2002,27(2):135-137. 被引量：4
-
9董振华.类风湿关节炎的社区预防及健康指导[J].中国全科医学,2002,5(9):683-684. 被引量：4
-
10王明明,梁茂本.1527张艾瑞昔布门诊用药处方分析[J].中国药业,2020,29(14):30-33. 被引量：3
-
1新型抗癫痫药的心血管危险性较小[J].中华医学信息导报,2009,24(8):10-10.
-
2调脂治疗可降低心血管危险性[J].中国处方药,2006,5(5):74-75.
-
3复方降脂新药葆至能上市[J].健康指南（中老年）,2012(7):9-9.
-
4默沙东公司新剂型抗艾滋病药物面市[J].中国药店,2003(2):94-94.
-
5FDA批准Noxafil缓释片上市[J].药学研究,2014,33(1):30-30.
-
6欧洲药品管理局再次警告依托考昔不适用于部分高血压患者[J].临床荟萃,2009,24(7):566-566.
-
7张立贤,王家双,彭亮,杨庆耿,王爱群,陈剑龄,舒慧芳.罗非昔布超前镇痛在无痛人流术中的应用[J].中国疼痛医学杂志,2005,11(1):22-24. 被引量：7
-
8崔旭蕾,郭向阳,任洪智.非甾体抗炎药及其心血管风险[J].临床麻醉学杂志,2007,23(3):256-257. 被引量：14
-
9刘静.04077 美过去3年从市场撤出的处方药[J].国外药讯,2001(4):32-32.
-
10NSAIDs药物的综合安全性[J].中国社区医师,2007,23(21):30-30.
